ALK-Abello A/S
F:4AJ0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ALK-Abello A/S
F:4AJ0
|
DK |
|
S
|
Step One Clothing Ltd
ASX:STP
|
AU |
|
U
|
United Therapeutics Corp
XMUN:UTH
|
US |
|
P
|
PG&E Corp
F:PCG
|
US |
|
Infosys Ltd
F:IOY
|
IN |
|
China Conch Venture Holdings Ltd
F:68C
|
CN |
|
A
|
Atlas Arteria Group
F:M82
|
AU |
|
E
|
Elbit Systems Ltd
SWB:EB2
|
IL |
|
E
|
E-Commodities Holdings Ltd
F:WWY1
|
CN |
|
P
|
PPL Corp
LSE:0KEJ
|
US |
|
P
|
PPL Corp
DUS:PP9
|
US |
|
P
|
PG&E Corp
DUS:PCG
|
US |
|
P
|
Providence Resources PLC
F:PZQA
|
IE |
|
M
|
MTN Group Ltd
XBER:LL6
|
ZA |
Bankruptcy Probability
ALK-Abello A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ALK-Abello A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
ALK-Abello A/S
CSE:ALK B
|
50.3B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
633.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
323.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
196.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
248.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ALK-Abello A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ALK-Abello A/S has total debt of 349m DKK. This includes both short-term (0 DKK) and long-term (349m DKK) debt.
You can find a full breakdown on its Balance Sheet.
